Use of potentially abusive psychotropic substances in psychiatric inpatients
Tóm tắt
A series of 417 consecutively admitted psychiatric inpatients were studied with regard to their use of potentially abusive psychotropic substances in the last 3 months preceding admission. In all patients face-to-face interviews were performed; in 354 of them urine specimens could also be tested. Alcohol and benzodiazepines belonged to the most frequently used substances followed by cannabis, opiates and cocaine. Barbiturates, hallucinogens and amphetamine derivatives were only exceptionally reported. The most important finding of the study is that every fifth patient regularly used “hard” drugs (opiates and/or cocaine), every fourth patient illegal drugs and every third patient alcohol. Substances were found in 54% of all urine specimens; methadone, opiates and cocaine were hardly found alone. For the latter substances excellent agreement was found between interview reports and urine exams. Excluding patients diagnosed as substanceuse disorders, there were no statistically significant differences between schizophrenic, affective, neurotic/stress/ somatoform and other disorders with regard to the use of “hard” drugs and illegal drugs. Regular substance use correlated with much worse psychosocial adjustment. Substance use has to be explored and considered in every individual psychiatric inpatient.
Tài liệu tham khảo
Adelekan ML, Gowers S, Singh D (1994) Reliability and validity of the Westminster Substance Use Questionnaire among Lancashire adolescents. Drug Alcohol Depend 34: 191–199
Andréasson S, Engström A, Allebeck P, Rydverg U (1987) Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet ii: 1483–1486
Andréasson S, Allebeck P, Rydberg U (1989) Schizophrenia in users and nonusers of cannabis. A longitudinal study in Stockholm County. Acta Psychiatr Scand 79: 505–510
Appleby L, Luchins DJ, Dyson V (1995) Effects of mandatory drug screens on substance use diagnoses in a mental hospital population. J Nerv Ment Dis 183: 183–184
Arndt S, Tyrrell G, Flaum M, Andreasen NC (1992) Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment. Psychol Med 22: 379–388
Baberg HT, Nelesen RA, Dimsdale JE (1996) Amphetamine use: return of an old scourge in a consultation psychiatry setting. Am J Psychiatry 153: 789–793
Barbee JG, Clark PD, Crapanzano MS, Heintz GC, Kehoe CE (1989) Alcohol substance abuse among schizophrenic patients presenting to an emergency psychiatric service. J Nerv Ment Dis 177: 400–407
Barry KL, Fleming MF, Greenley PW, Kropp S, McKee D (1995) Assessment of alcohol and other drug disorders in the seriously mentally ill. Schizophr Bull 21: 313–321
Bartels SJ, Drake RD, Wallch MA (1995) Long-term course of substance use disorders among patients with severe mental illness. Psychiatr Serv 46: 248–251
Bowers MB, Mazure CM, Nelson JC, Jatlow PI (1990) Psychotogenic drug use and neuroleptic response. Schizophr Bull 16: 81–85
Brady KT, Sonne SC (1995) The relationship between substance abuse and bipolar disorder. J Clin Psychiatry 56: 19–24
Brady K, Casto S, Lydiard RB, Malcolm R, Arana G (1991) Substance abuse in an inpatient psychiatric sample. Am J Drug Alcohol Abuse 17: 389–397
Breakey WR, Goodell H, Lorenz PC, McHugh PR (1974) Hallucinogenic drugs as precipitants of schizophrenia. Psychol Med 4: 255–261
Buckley P, Thompson P, Way L, Meltzer HY (1994) Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy. Am J Psychiatry 151: 385–389
Davis DI (1984) Differences in the use of substances of abuse by psychiatric patients compared with medical and surgical patients. J Nerv Ment Dis 172: 654–657
Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ (1990) Acute effects of drug abuse in schizophrenic patients: clinical observations and patients’ self-reports. Schizophr Bull 16: 69–79
Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ (1991) Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry 148: 224–230
Dixon L, Weiden PJ, Haas G, Sweeney J, Frances AJ (1992) Increased tardive dyskinesia in alcohol-abusing schizophrenic patients. Compr Psychiatry 33: 121–122
el-Guebaly N (1975) Manic-depressive psychosis and drug abuse. Can Psychiatr Assoc J 20: 595–598
Estroff TW, Dackis CA, Gold MS, Pottash ALC (1985) Drug abuse and biopolar disorders. Int J Psychiatry Med 15: 37–40
Group for the Advancement of Psychiatry, Committee on Alcoholism and the Addictions (1991) Substance abuse disorders: a psychiatric priority. Am J Psychiatry 148: 1291–1300
Gsellhofer B, Fahrner E-M, Platt J (1993) Deutsche Version von European Addiction Severity Index, EuropASI Fassung. Nach dem amerikanischen Original von McLellan T, 5th edn, 1992, und der europäischen Version EuropASI von Kokkevi A, Hartgers C, Blanken P, Fahrner E-M, Pozzi G, Tempesta E, Uchtenhagen A. IFT Institut für Therapieforschung, München
Gupta S, Hendricks S, Kenkel AM, Bhatia SC, Haffke EA (1996) Relapse in schizophrenia: Is there a relationship to substance abuse? Schizophr Res 20: 153–156
Hekimian LJ, Gershon S (1968) Characteristics of drug abusers admitted to a psychiatric hospital. JAMA 205: 125–130
Kales JP, Barone MA, Bixler EO, Miljkovic MM, Kales JD (1995) Mental illness and substance use among sheltered homeless persons in lower-density population areas. Psychiatr Serv 46: 592–595
Kokkevi A, Stefanis C (1995) Drug abuse and psychiatric comorbidity. Compr Psychiatry 36: 329–337
Lehman AF, Myers CP, Thompson JW, Corty E (1993) Implications of mental and substance use disorders. A comparison of single and dual diagnosis patients. J Nerv Ment Dis 181: 365–370
Lehman AF, Myers CP, Corty E, Thompson JW (1994 a) Prevalence and patterns of “dual diagnosis” among psychiatric inpatients. Compr Psychiatry 35: 106–112
Lehman AF, Myers CP, Corty E, Thompson J (1994 b) Severity of substance use disorders among psychiatric inpatients. J Nerv Ment Dis 182: 164–167
Lehman AF, Myers CP, Dixon LB, Johnson JL (1994 c) Defining subgroups of dual diagnosis patients for service planning. Hosp Community Psychiatry 45: 556–561
Miller FT, Busch F, Hertz Tanenbaum J (1989) Drug abuse in schizophrenia and bipolar disorder. Am J Alcohol Abuse 15: 291–295
Mirin SM, Weiss RD, Griffin ML, Michael JL (1991) Psychopathology in drug abusers and their families. Compr Psychiatry 32: 36–51
Mueser KT, Yarnold PR, Levinson DF, Singh H, Bellack AS, Kee K, Morrison RL, Yadalam KG (1990) Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull 16: 31–56
Mueser KT, Yarnold PR, Bellack AS (1992) Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psychiatr Scand 85: 48–55
Negrete JC, Knapp WP, Douglas DE, Smith WB (1986) Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey. Psychol Med 16: 515–520
Newman R, Miller N (1992) Substance abuse and psychosis. Curr Opin Psychiatry 5: 25–28
Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd JL, Goodwin FK (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. JAMA 264: 2511–2518
Ries R, Mullen M, Cox G (1994) Symptom severity and utilization of treatment resources among dually diagnosed inpatients. Hosp Community Psychiatry 45: 562–568
Rosenthal RN, Hellerstein DJ, Miner CR (1994) Positive and negative syndrome typology in schizophrenic patients with psychoactive substance use disorders. Compr Psychiatry 35: 91–98
Ross HE, Glaser FB, Germanson T (1988) The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch Gen Psychiatry 45: 1023–1031
Sanguineti VR, Samuel SE (1993) Reported prevalence of drug abuse comorbidity in a city-wide emergency room system. Am J Drug Alcohol Abuse 19: 443–450
Schneier FR, Siris SG (1987) A review of psychoactive substance use and abuse in schizophrenia. Patterns of drug choice. J Nerv Ment Dis 175: 641–652
Shaner A, Khalsa ME, Roberts L, Wilkins J, Anglin D, Hsieh S-C (1993) Unrecognized cocaine use among schizophrenic patients. Am J Psychiatry 150: 578–762
Sheehan MF (1993) Dual diagnosis. Psychiatr Q 64: 107–134
Silver H, Abboud E (1994) Drug abuse in schizophrenia: comparison of patients who began drug abuse before their first admission with those who began abusing drugs after their first admission. Schizophr Res 13: 57–63
Siris SG, Kane JM, Frechen K, Sellew AP, Mandeli J, Fasano-Dube B (1988) Histories of substance abuse in patients with postpsychotic depressions. Compr Psychiatry 29: 550–557
Smith J, Hucker S (1994) Schizophrenia and substance abuse. Br J Psychiatry 165: 13–21
Soyka M, Albus M, Kathmann N, Finelli A, Hofstetter S, Holzbach R, Immler B, Sand P (1993) Prevalence of alcohol and drug abuse in schizophrenic inpatients. Eur Arch Psychiatry Clin Neurosci 242: 362–372
Swofford CD, Kasckow JW, Scheller-Gilkey G, Inderbitzin LB (1996) Substance use: a powerful predictor of relapse in schizophrenia. Schizophr Res 20: 145–151
Treffert DA (1978) Marijuana use in schizophrenia: a clear hazard. Am J Psychiatry 135: 1213–1215
Tsuang MT, Simpson JC, Kronfol Z (1982) Subtypes of drug abuse with psychosis. Demographic characteristics, clinical features, and family history. Arch Gen Psychiatry 39: 141–147
Turner WM, Tsuang MT (1990) Impact of substance abuse on the course and outcome of schizophrenia. Schizophr Bull 16: 87–95
Walker RD, Howard MO, Lambert MD, Suchinsky R (1994) Psychiatric and medical comorbidities of veterans with substance use disorder. Hosp Community Psychiatry 45: 232–237
Zanis DA, McLellan AT, Randall M (1994) Can you trust patient self-reports of drug use during treatment? Drug Alcohol Depend 35: 127–132